Table 3.
HLA antibody analysis of patient 1
| C1q | Day342 | Day 456 | Day 580 | Day 780 | |
|---|---|---|---|---|---|
| B76 | 8891 | 5676 | 8284 | 2846 | |
| B45 | 8726 | 6285 | 9109 | 2793 | |
| B44* | 5761 | 5841 | 8768 | 2610 | |
| B8* | 5322 | 5482 | 8202 | 2636 | |
| A1* | 3371 | 5919 | 9084 | 5609 | |
| B82 | 2597 | 3344 | 5424 | 2314 | |
| A11* | 2474 | 5380 | 7831 | 6095 | |
| A36 | 2306 | 3495 | 5253 | 2301 | |
| A80 | 1901 | 2595 | 4095 | ND | |
| A2 | 1385 | 1955 | 2791 | 2377 | |
| A43 | 1383 | 2632 | 4919 | ND | |
| A66 | ND | 3149 | 5693 | 5296 | |
| A34 | ND | 3125 | 4977 | 4718 | |
| A3 | ND | 3086 | 4997 | ND | |
| A74 | ND | 3058 | 4958 | 3765 | |
| A31 | ND | 2977 | 4899 | 2849 | |
| A29 | ND | 2917 | 4501 | ND | |
| A68 | ND | 2869 | 4435 | 5646 | |
| A26 | ND | 2821 | 5730 | ND | |
| A33 | ND | 2634 | 4470 | 3360 | |
| A30 | ND | 2561 | 4057 | 4665 | |
| A69 | ND | 2352 | 4564 | 6202 | |
| A25 | ND | 2224 | 4237 | ND | |
| Cw7 | + | ND | 1640 | 2418 | ND |
| B59 | ND | ND | 1359 | ND | |
| A32 | ND | ND | 1319 | ND | |
| DQ4 | NA | 2637 | 4028 | ND | |
| DQ9 | NA | 2011 | 3006 | ND | |
| DQ8 | NA | 1929 | 2949 | ND | |
| DQ2* | NA | 1260 | 1916 | ND | |
| DQ7 | NA | 1136 | 1753 | ND | |
| DR4* | NA | 1050 | 1949 | ND | |
| DR12* | NA | ND | 1626 | ND | |
| DR53 | NA | ND | 1337 | ND |
*Donor‐specific antibody.
MFI values and C1q positivity for patient 1 on days 342, 456, 580, and 780. Day 780 is 220 days after liver transplantation. C1q reactivity was normalized to background and MFI values >1000 were considered positive. +, positive; MFI, mean fluorescence intensity; NA, not available; ND, below threshold limit of 1000 MFI.